Specjalistyczna Praktyka Lekarska prof. Grzegorz Opala
- Address
- lock Available on a paid plan
Specjalistyczna Praktyka Lekarska prof. Grzegorz Opala - Multiple Sclerosis Research Center
This specialized medical practice, led by Professor Grzegorz Opala, focuses on advancing the understanding and treatment of neurological disorders, with particular expertise in Multiple Sclerosis (MS). The center participates in cutting-edge clinical research evaluating novel therapeutic approaches for patients with MS.
- Long-term safety and efficacy evaluation of advanced MS therapies
- Rollover studies examining sustained treatment outcomes in Multiple Sclerosis patients
- Phase III pivotal trial participation for innovative immunomodulatory treatments
The practice demonstrates commitment to comprehensive MS care through participation in extended follow-up studies, including research on ocrelizumab therapy. This involvement in longitudinal research enables the center to provide patients with access to advanced treatment options while contributing valuable data on the longer-term safety profiles and sustained efficacy of emerging MS therapeutics.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 1 by active trials.
- 1Askbio Inc.1active
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 1 624 other sites in Poland
Therapeutic Area Benchmark — Poland
Select a therapeutic area to compare against other sites in Poland.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Poland
Market Share
Country: Poland
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Specjalistyczna Praktyka Lekarska prof. Grzegorz Opala
lock Showing 1 of 4 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| (ASK-PD0-CS002) Long-Term Safety and Efficacy Follow-up of AB-1005 Gene Transfer Study Participants with Parkinson’s Disease or Multiple System Atrophy | Askbio Inc. | Phase III | Not Yet Recruiting | — | — |
IMP list
lock Showing 1 of 8 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Adeno-Associated Viral Vector Serotype 2 Encoding Glial Cell Line-Derived Neurotrophic Factor | 1 | Unknown | — | — |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.